Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

Abbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in coronary ...

A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than their counterparts.

Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

In current European and American revascularization guidelines, RA grafts are now strongly endorsed as the second conduit for ...

Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...

In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of ...

Occurs when the walls of the coronary arteries become narrowed by a gradual fatty build-up. It may lead to angina or heart attack. A computerised axial tomography (CAT) or computed tomography (CT) ...

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...